To assess the relative frequency of reporting of adverse events involving ventricular arrhythmia, cardiac arrest, QTc prolongation, or torsade de pointes to the US Food and Drug Administration (FDA) between buprenorphine and methadone.Retrospective pharmacoepidemiologic ...
www.ncbi.nlm.nih.gov
"
Ventricular arrhythmia or cardiac arrest was reported in 1.8% of buprenorphine cases compared with 11.6% of methadone cases. Similarly, 0.3% of buprenorphine cases reported QTc prolongation/torsade de pointes compared with 2.6% of methadone cases. Torsade de pointes was reported in 0.1% of buprenorphine cases compared with 1.7% of methadone cases.
"
Generally not the sole agent involved.
Generally seems to require twice the maximum dosage of Butrans patches, so likely not a problem for pain physicians unless using very high dose Belbuca or Suboxone.
This site uses cookies to help personalize content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies and terms of service.